Literature DB >> 21660640

Endoscopic fundoplication: real or fantasy?

Alejandro Nieponice1, Blair A Jobe.   

Abstract

Mesh：

Year:  2011        PMID： 21660640     DOI： 10.1007/s11605-011-1580-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  14 in total

Review 1.  Effectiveness of laparoscopic fundoplication in relieving the symptoms of gastroesophageal reflux disease (GERD) and eliminating antireflux medical therapy.

Authors:  P K Papasavas; R J Keenan; W W Yeaney; P F Caushaj; D J Gagné; R J Landreneau
Journal:  Surg Endosc       Date:  2003-05-13       Impact factor: 4.584

2.  Twelve months' follow-up after treatment with the EndoCinch endoscopic technique for gastro-oesophageal reflux disease: a randomized, placebo-controlled study.

Authors:  Madeleine Montgomery; Bengt Håkanson; Olle Ljungqvist; Bo Ahlman; Anders Thorell
Journal:  Scand J Gastroenterol       Date:  2006-12       Impact factor: 2.423

Review 3.  Endoscopic implantation of enteryx for the treatment of gastroesophageal reflux disease: technique, pre-clinical and clinical experience.

Authors:  Hubert Louis; Jacques Devière
Journal:  Gastrointest Endosc Clin N Am       Date:  2003-01

4.  Endoluminal fundoplication (ELF) for GERD using EsophyX: a 12-month follow-up in a single-center experience.

Authors:  Alessandro Repici; Uberto Fumagalli; Alberto Malesci; Roberta Barbera; Camilla Gambaro; Riccardo Rosati
Journal:  J Gastrointest Surg       Date:  2009-11-10       Impact factor: 3.452

5.  Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using EsophyX.

Authors:  Guy-Bernard Cadière; Nathalie Van Sante; Jaime E Graves; Anna K Gawlicka; Amin Rajan
Journal:  Surg Endosc       Date:  2009-03-14       Impact factor: 4.584

6.  Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device.

Authors:  Blair A Jobe; Robert W O'Rourke; Barry P McMahon; Flemming Gravesen; Cedric Lorenzo; John G Hunter; Mary Bronner; Stefan J M Kraemer
Journal:  Ann Surg       Date:  2008-07       Impact factor: 12.969

7.  Effect of transoral incisionless fundoplication on symptoms, PPI use, and ph-impedance refluxes of GERD patients.

Authors:  Pier Alberto Testoni; Maura Corsetti; Salvatore Di Pietro; Antonio Gianluca Castellaneta; Cristian Vailati; Enzo Masci; Sandro Passaretti
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

8.  Transoral incisionless fundoplication for gastroesophageal reflux disease in an unselected patient population.

Authors:  Sebastian V Demyttenaere; Simon Bergman; Thomas Pham; Joel Anderson; Rebecca Dettorre; W Scott Melvin; Dean J Mikami
Journal:  Surg Endosc       Date:  2010-04       Impact factor: 4.584

9.  Endolumenal fundoplication with EsophyX: the initial North American experience.

Authors:  Simon Bergman; Dean J Mikami; Jeffrey W Hazey; Jason C Roland; Rebecca Dettorre; W Scott Melvin
Journal:  Surg Innov       Date:  2008-09       Impact factor: 2.058

Review 10.  Endoluminal GERD treatments: critical appraisal of current literature with evidence-based medicine instruments.

Authors:  Alfonso Torquati; William O Richards
Journal:  Surg Endosc       Date:  2007-03-31       Impact factor: 3.453
View more
  2 in total

1.  Revisional laparoscopic antireflux surgery after unsuccessful endoscopic fundoplication.

Authors:  Bart P L Witteman; Boudewijn F Kessing; Gitte Snijders; Ger H Koek; José M Conchillo; Nicole D Bouvy
Journal:  Surg Endosc       Date:  2013-01-05       Impact factor: 4.584

2.  Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice.

Authors:  Bart P L Witteman; Rob Strijkers; Eva de Vries; Liza Toemen; José M Conchillo; Wim Hameeteman; Pieter C Dagnelie; Ger H Koek; Nicole D Bouvy
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.